Read article – Quotes Bryan Luikart, assistant professor of molecular and systems biology, about a new study that reveals that scientists have successfully corrected a dangerous mutation in genes in human embryos, fixing a mutation that causes a common heart condition that can lead to sudden death later in life. “It is pretty amazing. It is a super-exciting time to be a scientist right now,” says Luikart, who was not involved in the study.
This 10-Second Quiz Can Tell You if You Should Get Screened for Lung Cancer – TIME
Read article – Quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of economics, about the importance of remembering that getting screened for cancer has benefits and risks, and that it should be a personal decision—even for people who are high-risk.
Nature Index Profile: Michael Sporn: A Legacy of Greater Knowledge
Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Five Things to Know About Gastroenteritis – CNN
Read article – Cites comments by Corey Siegel, associate professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article that shares five facts about gastroenteritis. Siegel, a gastroenterologist, notes that the elderly are at especially high risk of getting dehydrated when they have gastroenteritis, and that dehydration can lead to kidney problems.
How to Have a Successful Freshman Year as a Premedical Student – The Student Doctor Network
Read article – An opinion piece by Cassie Kosarek, Geisel ’20, in which she discusses how new premedical students can maximize their success during their freshman year of college.
Critical Condition: Primary Care Providers in Very Short Supply in Twin States – Valley News
Read article – Quotes Cathleen Morrow, chair and associate professor of community and family medicine, and Aurora Robledo, Geisel ’18, in an article about how many hospitals in Vermont and New Hampshire have trouble attracting and maintaining the primary care workforce they need.
To Diversify Med Schools, Focus on Completion – Inside Higher Ed
Read article – An opinion piece by Julie Kim, assistant professor of pediatrics, in which she discusses the factors that play a role in making underrepresented minorities less likely to graduate from medical school. (Kim is participating in this year’s Dartmouth Public Voices project.)
Too Many Meds? America’s Love Affair With Prescription Medication – Consumer Reports
Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article that examines America’s reliance on pharmaceuticals, and the role that marketing companies play in encouraging the consumption of pharmaceuticals. “Low T is a marketing term intended to sell testosterone as a kind of fountain of youth,” says Woloshin. For most men, he says, testosterone “declines naturally with age,” and research shows that taking drugs to compensate has “little or no benefit” and “some serious risks.”
Fear, Not Compassion, Drives ACA Repeal Effort – in-Training
Read article – An opinion piece by Reza Hessabi, Geisel ’20, in which he discusses his experience working as a field organizer for President Obama’s re-election campaign and how he saw people’s lives changed for the better with the Affordable Care Act’s passing.
Number of Mass. Fentanyl Deaths Alarms DEA – The Boston Globe
Read article – Quotes Lisa Marsch, director of the Center for Technology and Behavioral Health (CTBH) and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, about how she and additional colleagues released a study in June that pointed to Lawrence, Mass., as a major gateway for the fentanyl ravaging New Hampshire. Marsch, who led the study, said the sudden shift from heroin to fentanyl has been startling. “That’s what people want now,” says Marsch. “They want this more potent product.